Current:Home > InvestModerna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds-LoTradeCoin
Moderna-Merck vaccine cuts odds of skin cancer recurrence in half, study finds
View Date:2024-12-24 00:50:39
A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck announced on Thursday.
Those with severe melanomas who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years than those who were given only Keytruda, the biotech companies said in a news release.
The findings are based on an ongoing randomized trial involving 157 patients with high-risk stage III/IV melanoma who first had surgery to completely remove cancerous growths. Patients received one milligram of the mRNA vaccine every three weeks for nine doses, and 200 milligrams of Keytruda every three weeks for about a year versus Keytruda alone for approximately a year.
The companies have begun Phase 3 trials of mRNA-4157 with Keytruda for people with stage III and IV melanoma. The Food and Drug Administration earlier this year designated the treatment as a breakthrough therapy in order to expedite the development and review of drugs meant to treat life-threatening diseases.
"We look forward to sharing these data with people impacted by the disease and the broader scientific community," Kyle Holen, M.D., Moderna's senior vice president and head of development, therapeutics and oncology, stated.
The results are a vindication of sorts for Moderna's strategy to develop new uses for messenger RNA technology used in its COVID-19 vaccine. Cambridge, Massachusetts-based Moderna said in November it anticipates a steep decline in revenue next year, fueling worries about its capacity to finance multiple product launches planned for 2024 and 2025.
Skin cancer is the most common form of cancer, with melanoma accounting for only about 1% of skin cancer cases in the U.S. That said, it causes a large majority of skin cancer deaths, according to the American Cancer Society. It estimates about 97,610 new melanomas will be diagnosed in the U.S. this year, resulting in 7,990 deaths.
Moderna's stock has cratered this year, falling 50%. On Thursday, its shares shot up 12% in mid-day trading to $87.93.
Rahway, New Jersey-based Merck shares treaded water, down 0.2% at $106.16.
- In:
- Moderna
- Cancer
- Merck
Kate Gibson is a reporter for CBS MoneyWatch in New York.
veryGood! (177)
Related
- CFP bracket prediction: SEC adds a fifth team to field while a Big Ten unbeaten falls out
- House Republicans are mired in chaos after ousting McCarthy and rejecting Scalise. What’s next?
- Biden Announces Huge Hydrogen Investment. How Much Will It Help The Climate?
- Site of Israeli music festival massacre holds shocking remnants of the horrific attack
- Pete Rose fans say final goodbye at 14-hour visitation in Cincinnati
- The history of skirts (the long and the short of it)
- Blast strikes Shiite mosque during Friday prayers in Afghanistan’s north
- Gunmen kill 6 construction workers in volatile southwestern Pakistan
- Report: Jaguars' Trevor Lawrence could miss rest of season with shoulder injury
- Iowa jurors clear man charged with murder in shooting deaths of 2 students
Ranking
- 'SNL' stars jokingly declare support for Trump, Dana Carvey plays Elon Musk
- Workers with in-person jobs spend about $51 a day that they wouldn't remotely, survey finds
- Solar eclipse livestream: Watch Saturday's rare 'ring of fire' annual eclipse live
- Medicare Part B premiums for 2024 will cost more: Here's how much you'll pay
- Opinion: Chris Wallace leaves CNN to go 'where the action' is. Why it matters
- Carlee Russell ordered to pay almost $18,000 for hoax kidnapping, faces jail time
- Hunter Biden investigations lead to ethical concerns about President Biden, an AP-NORC poll shows
- Rudolph Isley, founding member of The Isley Brothers, dead at 84
Recommendation
-
UConn, Kansas State among five women's college basketball games to watch this weekend
-
‘Barbenheimer’ was a boon to movie theaters and a headache for many workers. So they’re unionizing
-
Dean McDermott Holds Hands With Lily Calo After Tori Spelling Breakup
-
Medicare Part B premiums for 2024 will cost more: Here's how much you'll pay
-
Family of security guard shot and killed at Portland, Oregon, hospital sues facility for $35M
-
Hamas 'Day of Rage' protests break out in Middle East and beyond
-
Americans failed to pay record $688 billion in taxes in 2021, IRS says. Look for more audits.
-
Michelle Williams to Narrate Britney Spears' Upcoming Memoir The Woman in Me